
|Videos|June 12, 2015
Federal Compounding Law and Health-System Pharmacists
Chris Topoleski, director of federal regulatory affairs for ASHP discusses how the federal compounding law will affect health-system pharmacists.
Advertisement
Chris Topoleski, director of federal regulatory affairs for ASHP discusses how the federal compounding law will affect health-system pharmacists.
This video was taken at ASHP's Summer Meetings and Exposition in June 2015.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Nufymco, Interchangeable Ranibizumab Biosimilar, for Retinal Diseases
2
Achieving Optimal LDL-C Helps Prevent Neoatherosclerosis, Late Stent Failure in Patients With STEMI
3
FDA Approves Milestone Oral Therapy for Adults With Thalassemia Anemia
4
FDA Approves First Oral GLP-1 for Weight Management
5







































































































































































































